1887

Abstract

is the most common organism associated with asymptomatic bacteriuria (ABU). In contrast to uropathogenic (UPEC), which causes symptomatic urinary tract infection (UTI), very little is known about the mechanisms by which these strains colonize the urinary tract. Bacterial adhesion conferred by specific surface-associated adhesins is normally considered as a prerequisite for colonization of the urinary tract. The prototype ABU strain 83972 was originally isolated from a girl who had carried it asymptomatically for 3 years. This study characterized the molecular status of one of the primary adhesion factors known to be associated with UTI, namely F1C fimbriae, encoded by the gene cluster. F1C fimbriae recognize receptors present in the human kidney and bladder. Expression of the genes was found to be up-regulated in human urine. It was also shown that although strain 83972 contains a seemingly intact gene cluster, F1C fimbriae are not expressed. Sequencing and genetic complementation revealed that the gene, encoding a component of the F1C transport and assembly system, was non-functional, explaining the inability of strain 83972 to express this adhesin. The data imply that 83972 has lost its ability to express this important colonization factor as a result of host-driven evolution. The ancestor of the strain seems to have been a pyelonephritis strain of phylogenetic group B2. Strain 83972 therefore represents an example of bacterial adaptation from pathogenicity to commensalism through virulence factor loss.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.28711-0
2006-06-01
2020-02-22
Loading full text...

Full text loading...

/deliver/fulltext/micro/152/6/1799.html?itemId=/content/journal/micro/10.1099/mic.0.28711-0&mimeType=html&fmt=ahah

References

  1. Andersson P, Engberg I, Lidin-Janson G, Lincoln K, Hull R, Hull S, Svanborg C. 1991; Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun59:2915–2921
    [Google Scholar]
  2. Bachmann B. J. others 1996; Derivations and genotypes of some mutant derivatives of Escherichia coli K-12. In Escherichia coli and Salmonella: Cellular and Molecular Biology, 2nd edn. pp 2460–2488 Edited by Neidhardt F. C.. Washington, DC: American Society for Microbiology;
    [Google Scholar]
  3. Bäckhed F, Alsen B, Roche N, Angstrom J, Breimer M. E, Westerlund-Wikstrom B, Teneberg S, Richter-Dahlfors A, von Euler A. 2002; Identification of target tissue glycosphingolipid receptors for uropathogenic, F1C-fimbriated Escherichia coli and its role in mucosal inflammation. J Biol Chem277:18198–18205[CrossRef]
    [Google Scholar]
  4. Darouiche R. O, Donovan W. H, Del Terzo M, Thornby J. I, Rudy D. C, Hull R. A. 2001; Pilot trial of bacterial interference for preventing urinary tract infection. Urology58:339–344[CrossRef]
    [Google Scholar]
  5. Datsenko K. A, Wanner B. L. 2000; One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A97:6640–6645[CrossRef]
    [Google Scholar]
  6. Eden C. S, Hanson L. A, Jodal U, Lindberg U, Akerlund A. S. 1976; Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet1:490–492
    [Google Scholar]
  7. Foxman B. 2002; Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med113:5S–13S
    [Google Scholar]
  8. Funfstuck R, Tschape H, Stein G, Kunath H, Bergner M, Wessel G. 1986; Virulence properties of Escherichia coli strains in patients with chronic pyelonephritis. Infection14:145–150[CrossRef]
    [Google Scholar]
  9. Hedlund M, Duan R. D, Nilsson A, Svensson M, Karpman D, Svanborg C. 2001; Fimbriae, transmembrane signaling, and cell activation. J Infect Dis183:S47–S50[CrossRef]
    [Google Scholar]
  10. Hull R. A, Rudy D. C, Donovan W. H, Wieser I. E, Stewart C, Darouiche R. O. 1999; Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun67:429–432
    [Google Scholar]
  11. Hull R, Rudy D, Donovan W, Svanborg C, Wieser I, Stewart C, Darouiche R. 2000; Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol163:872–877[CrossRef]
    [Google Scholar]
  12. Johnson J. R. 1991; Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev4:80–128
    [Google Scholar]
  13. Johnson J. R, Delavari P, Kuskowski M, Stell A. L. 2001; Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli . J Infect Dis183:78–88[CrossRef]
    [Google Scholar]
  14. Kaijser B, Ahlstedt S. 1977; Protective capacity of antibodies against Escherichia coli and K antigens. Infect Immun17:286–289
    [Google Scholar]
  15. Khan A. S, Kniep B, Oelschlaeger T. A, Van Die I, Korhonen T, Hacker J. 2000; Receptor structure for F1C fimbriae of uropathogenic Escherichia coli . Infect Immun68:3541–3547[CrossRef]
    [Google Scholar]
  16. Kjaergaard K, Schembri M. A, Ramos C, Molin S, Klemm P. 2000; Antigen 43 facilitates formation of multispecies biofilms. Environ Microbiol2:695–702[CrossRef]
    [Google Scholar]
  17. Klemm P, Schembri M. A. 2000; Bacterial adhesins: function and structure. Int J Med Microbiol290:27–35[CrossRef]
    [Google Scholar]
  18. Klemm P, Christiansen G, Kreft B, Marre R, Bergmans H. 1994; Reciprocal exchange of minor components of type 1 and F1C fimbriae results in hybrid organelles with changed receptor specificities. J Bacteriol176:2227–2234
    [Google Scholar]
  19. Klemm P, Jorgensen B. J, Kreft B, Christiansen G. 1995; The export systems of type 1 and F1C fimbriae are interchangeable but work in parental pairs. J Bacteriol177:621–627
    [Google Scholar]
  20. Klemm P, Roos V, Ulett G. C, Svanborg C, Schembri M. A. 2006; Molecular characterisation of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun74:781–785[CrossRef]
    [Google Scholar]
  21. Li C, Wong W. H. 2001; Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A98:31–36[CrossRef]
    [Google Scholar]
  22. Lindberg U, Hanson L. A, Jodal U, Lidin-Janson G, Lincoln K, Olling S. 1975; Asymptomatic bacteriuria in schoolgirls. II. Differences in Escherichia coli causing asymptomatic bacteriuria. Acta Paediatr Scand64:432–436[CrossRef]
    [Google Scholar]
  23. Moran N. A. 2002; Microbial minimalism: genome reduction in bacterial pathogens. Cell108:583–586[CrossRef]
    [Google Scholar]
  24. Mulvey M. A, Lopez-Boado Y. S, Wilson C. L, Roth R, Parks W. C, Heuser J, Hultgren S. J. 1998; Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli . Science282:1494–1497[CrossRef]
    [Google Scholar]
  25. Oelschlaeger T. A, Dobrindt U, Hacker J. 2002; Virulence factors of uropathogens. Curr Opin Urol12:33–38[CrossRef]
    [Google Scholar]
  26. Orskov I, Svanborg Eden C, Orskov F. 1988; Aerobactin production of serotyped Escherichia coli from urinary tract infections. Med Microbiol Immunol177:9–14
    [Google Scholar]
  27. Ott M, Jann K, Hacker J, Hoschützky H, van Die I. 1988; Gene clusters for S fimbrial adhesin (sfa) and F1C fimbriae (foc) of Escherichia coli : comparative aspects of structure and function. J Bacteriol170:3983–3990
    [Google Scholar]
  28. Pere A, Nowicki B, Saxen H, Siitonen A, Korhonen T. K. 1987; Expression of P, type 1, and type 1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J Infect Dis156:567–574[CrossRef]
    [Google Scholar]
  29. Plos K, Carter T, Hull S, Hull R, Svanborg Eden C. 1990; Frequency and organization of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli . J Infect Dis161:518–524[CrossRef]
    [Google Scholar]
  30. Plos K, Connell H, Jodal U, Marklund B. I, Marild S, Wettergren B, Svanborg C. 1995; Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J Infect Dis171:625–631[CrossRef]
    [Google Scholar]
  31. Roos V, Ulett G. C, Schembri M. A, Klemm P. 2006; The asymptomatic bacteriuria Escherichia coli strain 83972 out-competes UPEC strains in human urine. Infect Immun74:615–624[CrossRef]
    [Google Scholar]
  32. Samuelsson P, Hang L, Wullt B, Irjala H, Svanborg C. 2004; Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun72:3179–3186[CrossRef]
    [Google Scholar]
  33. Siitonen A, Martikainen R, Palmgren J, Ikäheimo R, Mäkelä P. H. 1993; Virulence-associated characteristics of Escherichia coli in urinary tract infection: a statistical analysis with special attention to type 1C fimbriation. Microb Pathog15:65–75[CrossRef]
    [Google Scholar]
  34. Snyder J. A, Haugen B. J, Lockatell C. V, Maroncle N, Hagan E. C, Johnson D. E, Welch R. A, Mobley H. L. T. 2005; Coordinate expression of fimbriae in uropathogenic Escherichia coli . Infect Immun73:7588–7596[CrossRef]
    [Google Scholar]
  35. Sokurenko E. V, Courtney H. S, Ohman D. E, Klemm P, Hasty D. L. 1994; FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes. J Bacteriol176:748–755
    [Google Scholar]
  36. Sokurenko E. V, Courtney H. S, Maslow J, Siitonen A, Hasty D. L. 1995; Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol177:3680–3686
    [Google Scholar]
  37. Sokurenko E. V, Feldgarden M, Trintchina E, Weissman S. J, Avagyan S, Chattopadhyay S, Johnson J. R, Dykhuizen D. E. 2004; Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli . Mol Biol Evol21:1373–1383[CrossRef]
    [Google Scholar]
  38. Stenqvist K, Sandberg T, Lidin-Janson G, Orskov F, Orskov I, Svanborg-Eden C. 1987; Virulence factors of Escherichia coli in urinary isolates from pregnant women. J Infect Dis156:870–877[CrossRef]
    [Google Scholar]
  39. Trautner B. W, Darouiche R. O, Hull R. A, Hull S, Thornby J. I. 2002; Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis . J Urol167:375–379[CrossRef]
    [Google Scholar]
  40. Trautner B. W, Hull R. A, Darouiche R. O. 2003; Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology61:1059–1062[CrossRef]
    [Google Scholar]
  41. van Die I, van Geffen B, Hoekstra W, Bergmans H. 1985; Type 1C fimbriae of a uropathogenic Escherichia coli strain: cloning and characterization of the genes involved in the expression of the 1C antigen and nucleotide sequence of the subunit gene. Gene34:187–196[CrossRef]
    [Google Scholar]
  42. Welch R. A, Burland V, Plunkett G., 3rd. 16 other authors 2002; Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli . Proc Natl Acad Sci U S A99:17020–17024[CrossRef]
    [Google Scholar]
  43. Wullt B. 2003; The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents21:605–621[CrossRef]
    [Google Scholar]
  44. Wullt B, Connell H, Rollano P, Mansson W, Colleen S, Svanborg C. 1998; Urodynamic factors influence the duration of Escherichia coli bacteriuria in deliberately colonized cases. J Urol159:2057–2062[CrossRef]
    [Google Scholar]
  45. Wullt B, Bergsten G, Connell H, Rollano P, Gebretsadik N, Hull R, Svanborg C. 2000; P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol38:456–464[CrossRef]
    [Google Scholar]
  46. Wullt B, Bergsten G, Fischer H.8 other authors 2003; The host response to urinary tract infection. Infect Dis Clin North Am17:279–301[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.28711-0
Loading
/content/journal/micro/10.1099/mic.0.28711-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error